• Product NameRecombinant Human TNFRSF10C
• Brief DescriptionRecombinant Protein
• Immunogen DescriptionFusion protein corresponding to a region derived from 26-236 amino acids of human TNFRSF10C
• Target Nametumor necrosis factor receptor superfamily member 10c
• Alternative Names    LIT; DCR1; TRID; CD263; TRAILR3; TRAIL-R3; DCR1-TNFR
• Accession No. Swissprot:O14798
  Gene Accession:BC125041
• UniprotO14798
• Gene ID8794;
• Storage -20~-80˚C, pH 7.6 PBS

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.

Note: For in vitro research use only, not for diagnostic or therapeutic use. This product is not a medical device.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting